DRG uses cookies to improve your experience on this website. Some of the cookies we use are essential for parts of the website to operate. Please be aware that if you continue without changing your cookie settings, you consent to this. For more information on our use of cookies, please review our cookie policy.


Understand the complete disease landscape and size global markets with real-world data.

165+ Diseases & Biomarkers | 45 Countries | 3,500+ Patient Segments


Get to a deeper level of understanding with DRG Epidemiology.

  • Extensive insights of oncology populations by stage, line of therapy, and biomarker
  • Expanding rare and niche disease coverage
  • Highest-profile disease coverage with ~90% of the global population
  • Growing emerging market coverage across all regions
  • Bottom-up patient-level forecasts
  • Rigorous methodology refined over two decades

Our industry-leading experts are available for ad-hoc projects and on-site support.

  • Comprehensive literature review
  • Cancer progression modeling and eligible patient sizing
  • Market sizing for complex indications
  • Rare disease epidemiology
  • Pharmacovigilance/drug safety
  • Customized patient flows
  • Corporate strategy and pipeline evaluation
  • Budget impact analysis
  • Sub-national US population sizing


Contact us today to learn how DRG can help you unlock hidden potential with Epidemiology.

Learn more